Connexin 43 and tumors

Abstract

Wen Xiaorong*, Mo Hongmei, Guo Tao, Ding Mengting. Connexin 43 and tumors[J]. Journal of International Oncology, 2018, 45(1): 32-.

［1］ Grek CL, Rhett JM, Ghatnekar GS. Cardiac to cancer: connecting connexins to clinical opportunity［J］. FEBS Lett, 2014, 588(8): 13491364. DOI: 10.1016/j.febslet.2014.02.047. ［2］ Rhett JM, Fann SA, Yost MJ. Purinergic signaling in early inflammatory events of the foreign body response: modulating extracellular ATP as an enabling technology for engineered implants and tissues［J］. Tissue Eng Part B Rev, 2014, 20(5): 392402. DOI: 10.1089/ten.TEB.2013.0554. ［3］ Jin Z, Xu S, Yu H, et al. miR125b inhibits Connexin43 and promotes glioma growth［J］. Cell Mol Neurobiol, 2013, 33(8): 11431148. DOI: 10.1007/s1057101399801. ［4］ Ableser MJ, Penuela S, Lee J, et al. Connexin43 reduces melanoma growth within a keratinocyte microenvironment and during tumorigenesis in vivo［J］. J Biol Chem, 2014, 289(3): 15921603. DOI: 10.1074/jbc.M113.507228. ［5］ Chen R, Luan Y, Liu Z, et al. AR pathway is involved in the regulation of CX43 in prostate cancer［J］. Biomed Res Int, 2015, 2015: 514234. DOI: 10.1155/2015/514234. ［6］ Macdonald AI, Sun P, HernandezLopez H, et al. A functional interaction between the MAGUK protein hDIg and the gap junction protein connexin 43 in cervical tumour cells［J］. Biochem J, 2012, 446(1): 921. DOI: 10.1042/BJ20111144. ［7］ Sun P, Dong L, MacDonald AI, et al. HPV16 E6 controls the gap junction protein Cx43 in cervical tumour cells［J］. Viruses, 2015, 7(10): 52435256. DOI: 10.3390/v7102871. ［8］ Sulkowska U, Wincewicz A, KanczugaKoda L, et al. Eventual proapoptotic or antiapoptotic impact of aberrantly expressed Cx43 and Cx26 can depend on ERalpha overexpression in human endometrioid adenocarcinoma［J］. Gynecol Endocrinol, 2015, 31(8): 604608. DOI: 10.3109/09513590.2015.1017811. ［9］ Matharu G, Tucker O, Alderson D. Systematic review of intraperitoneal chemotherapy for gastric cancer［J］. Br J Surg, 2011, 98(9): 12251235. DOI: 10.1002/bjs.7586. ［10］ Tang B, Peng ZH, Yu PW, et al. Aberrant expression of Cx43 is associated with the peritoneal metastasis of gastric cancer and Cx43mediated gap junction enhances gastric cancer cell diapedesis from peritoneal mesothelium［J］. PLoS One, 2013, 8(9): e74527. DOI: 10.1371/journal.pone.0074527. ［11］ Fu Y, Shao ZM, He QZ, et al. HsamiRV206 represses the proliferation and invasion of breast cancer cells by targeting Cx43［J］. Eur Rev Med Pharmacol Sci, 2015, 19(11): 20912104. ［12］ Lamiche C, Clarhaut J, Strale PO, et al. The gap junction protein Cx43 is involved in the bonetargeted metastatic behaviour of human prostate cancer cells［J］. Clin Exp Metastasis, 2012, 29(2): 111122. DOI: 10.1007/s1058501194344. ［13］ Zhang A, Hitomi M, BarShain N, et al. Connexin 43 expression is associated with increased malignancy in prostate cancer cell lines and functions to promote migration［J］. Oncotarget, 2015, 6(13): 1164011651. DOI: 10.18632/oncotarget.3449. ［14］ Qiu X, Cheng JC, Zhao J, et al. Transforming growth factorβ stimulates human ovarian cancer cell migration by upregulating connexin43 expression via Smad2/3 signaling［J］. Cell Signal, 2015, 27(10): 19561962. DOI: 10.1016/j.cellsig.2015.07.010. ［15］ Liu X, Cao K, Xu C, et al. GATA3 augmentation downregulates Connexin43 in helicobacter pylori associated gastric carcinogenesis［J］. Cancer Biol Ther, 2015, 16(6): 987996. DOI: 10.1080/15384047.2015.1030552. ［16］ Ming J, Zhou Y, Du J, et al. miR381 suppresses C/EBPαdependent Cx43 expression in breast cancer cells［J］. Biosci Rep, 2015, 35(6). pii: e00266. DOI: 10.1042/BSR20150167. ［17］ Brockmeyer P, Hemmerlein B, Jung K, et al. Connexin subtype expression during oral carcinogenesis: a pilot study in patients with oral squamous cell carcinoma［J］. Mol Clin Oncol, 2016, 4(2): 298302. DOI: 10.3892/mco.2015.685. ［18］ Brockmeyer P, Jung K, Perske C, et al. Membrane connexin 43 acts as an independent prognostic marker in oral squamous cell carcinoma［J］. Int J Oncol, 2014, 45(1): 273281. DOI: 10.3892/ijo.2014.2394. ［19］ Ismail R, Rashid R, Andrabi K, et al. Pathological implications of Cx43 downregulation in human colon cancer［J］. Asian Pac J Cancer Prev, 2014, 15(7): 29872991. ［20］曹建, 孙萍. Ⅱ期结肠癌的辅助化学治疗［J］. 国际肿瘤学杂志, 2013, 40(6): 463465. DOI: 10.3760/cma. j.issn.1673422X.2013.06.020. ［21］ Wang J, Dai Y, Huang Y, et al. Alltrans retinoic acid restores gap junctional intercellular communication between oral cancer cells with upregulation of Cx32 and Cx43 expressions in vitro［J］. Med Oral Patol Oral Cir Bucal, 2013, 18(4): e569e577. ［22］ Forster T, Rausch V, Zhang Y, et al. Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43mediated gap junctional intercellular communication［J］. Oncotarget, 2014, 5(6): 16211634. DOI: 10.18632/oncotarget.1764. ［23］ Grek CL, Rhett JM, Bruce JS, et al. Targeting connexin 43 with αconnexin carboxylterminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1［J］. BMC Cancer, 2015, 15: 296. DOI: 10.1186/s1288501512296. ［24］ Ghosh S, Kumar A, Chandna S. Connexin43 downregulation in G2/M phase enriched tumour cells causes extensive lowdose hyperradiosensitivity (HRS) associated with mitochondrial apoptotic events［J］. Cancer Lett, 2015, 363(1): 4659. DOI: 10.1016/j.canlet.2015.03.046.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments